IP Library Granted Patent US 11,844,856
Granted Patent B2
US 11,844,856 · App. 17/352,740 · Granted Dec 19, 2023

Solid drug tablets for implantable drug delivery devices

Inventors: Karen Danielle Daniel (Newton, MA); Burleigh M. Hutchins, III (Upton, MA); Cheryl Larrivee-Elkins (Framingham, MA); Heejin Lee (Bedford, MA)
Assignee: TARIS Biomedical LLC
A61K9/0004A61K9/0034A61K9/2027A61K9/2031A61K9/2072A61K9/2095A61K31/165A61K31/167A61M31/002A61M31/007B65B1/16A61K9/2004A61K31/16A61M2202/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,844,856
App. No.
17/352,740
Granted
Dec 19, 2023
Kind
B2
Abstract

A drug dosage form is provided in the form of a solid tablet which is greater than 50% by weight the local anesthetic agent. The local anesthetic agent may be selected from the group consisting of an aminoamide, an aminoester, and a combination thereof. The drug tablet may be in the form of a mini-tablet which is greater than 70 wt % drug, with the balance being excipient. For example, the anesthetic agent may include lidocaine, in a salt or base form, combined with binder and lubricant excipients. Implantable drug delivery devices including the tablets are also provided, e.g., one or more of the drug tablets may be contained in a biocompatible housing. The drug tablets may be substantially cylindrical with flat end faces, and the device may have from 10 to 100 drug tablets aligned in the housing with the flat end faces of adjacent tablets abutting one another.

Claims (9)

1. An intravesical device, comprising:

a device body; and

an assembly of drug units comprising a plurality of drug units in the form of mini-tablets containing a drug, the assembly being disposed within the device body,

wherein each mini-tablet is cylindrical with flat end faces, the length of the mini-tablet exceeding its diameter so that the mini-tablet has an aspect ratio of greater than 1:1; and

wherein the plurality of drug units are configured in a serial arrangement in which the flat end faces of adjacent drug units face one another.

2. The intravesical device of claim 1 , wherein the device is deformable and the drug units are configured such that they can move relative to adjacent drug units.

3. The intravesical device of claim 1 , wherein the device is configured for deployment into and retention within the bladder.

4. The intravesical device of claim 3 , wherein the device is configured for deployment through a cystoscope or catheter.

5. The intravesical device of claim 1 , wherein the drug comprises a chemotherapeutic agent and the mini-tablet comprises the drug in an amount between 70 wt % and 99 wt % of the mini-tablet.

Assignments (4)
MERGER Recorded May 6, 2026
From: TARIS BIOMEDICAL LLC
To: JANSSEN BIOTECH, INC.
Reel/Frame 074576/0807 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 24, 2021
From: DANIEL, KAREN DANIELLE; HUTCHINS, BURLEIGH M., III; LARRIVEE-ELKINS, CHERYL; LEE, HEEJIN
To: TARIS BIOMEDICAL INC.
Reel/Frame 056651/0507 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 24, 2021
From: LIRIS BIOMEDICAL, INC.
To: TARIS BIOMEDICAL LLC
Reel/Frame 056651/0802 →
CHANGE OF NAME Recorded Jun 24, 2021
From: TARIS BIOMEDICAL INC.
To: LIRIS BIOMEDICAL, INC.
Reel/Frame 056670/0425 →
Continuity (7)
Continuation 16932229 · Jul 17, 2020
Continuation 15633492 · Jun 26, 2017
Continuation 13729974 · Dec 28, 2012
Continuation 12825238 · Jun 28, 2010
Provisional Application 61241382 · Sep 10, 2009
Provisional Application 61220865 · Jun 26, 2009
Related Publication 20210308039A1 · Oct 7, 2021